Heirloom Wealth Management Astrazeneca PLC Transaction History

Heirloom Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$69.91 - $75.81 $164,288 - $178,153	2,350 Added 3.4%	71,508 $5.12 Million
Q1 2023 Apr 27, 2023	BUY	$63.15 - $71.6 $1.32 Million - $1.49 Million	20,829 Added 43.1%	69,158 $4.8 Million
Q4 2022 Feb 01, 2023	SELL	$54.21 - $70.44 $915,932 - $1.19 Million	-16,896 Reduced 25.9%	48,329 $3.28 Million
Q2 2022 Aug 10, 2022	BUY	$59.26 - $71.14 $341,633 - $410,122	5,765 Added 9.7%	65,225 $4.3 Million
Q1 2022 May 17, 2022	BUY	$55.72 - $67.12 $3.31 Million - $3.99 Million	59,460 New	59,460 $3.75 Million

1,360

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Heirloom Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Heirloom Wealth Management with notifications on news.